MindMaze Therapeutics Holding SA (SWX:MMTX)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
0.1900
+0.0002 (0.11%)
Aug 21, 2026, 5:31 PM CET

SWX:MMTX Financials Overview

Millions CHF. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024
Period EndingDec '25 Dec '25 Dec '24
Revenue
0.640.64-
Revenue Growth
---
Gross Profit
0.590.59-
Operating Income
-10.52-10.52-0
Net Income
-9.91-9.91-0
Earnings Per Share
-0.48-0.48-0.00
EPS Growth
---

Revenue by Geography

Fiscal YearTTMFY 2025
Period EndingDec '25 Dec '25
Asia
0.260.26
USA
0.170.17
Europe (Excl. Switzerland)
0.140.14
Switzerland
0.060.06
Rest of The World
0.020.02
Total
0.640.64

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024
Period EndingDec '25 Dec '25 Dec '24
Cash & Investments
9.559.55-
Total Debt
1.811.81-
Net Cash (Debt)
7.747.74-
Net Cash Growth
---
Net Cash Per Share
0.380.38-

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024
Period EndingDec '25 Dec '25 Dec '24
Operating Cash Flow
-7.21-7.21-0
Capital Expenditures
-6.24-6.24-
Free Cash Flow
-13.45-13.45-0
Free Cash Flow Growth
---

Margins

Fiscal YearTTMFY 2025FY 2024
Period EndingDec '25 Dec '25 Dec '24
Gross Margin
92.06%92.06%-
Operating Margin
-1637.85%-1637.85%-
Pretax Margin
-1542.99%-1542.99%-
Profit Margin
-1542.99%-1542.99%-
FCF Margin
-2094.39%-2094.39%-

Valuation

Fiscal YearCurrentFY 2025FY 2024
Period EndingAug '26 Dec '25 Dec '24
PS Ratio
45.16451.62-